Table 5.

Protocol used—based on type of cancer (survey responses per center)

Does your unit have differences in treatment protocols based on the type of the malignancy?
Yes	No	Our unit does not treat patients for fertility preservation
204 (63.6%)	85 (26.5%)	32 (10%)
In patients with malignant hematological diseases, when do you start fertility preservation treatment?
Immediately	Wait for the follicular phase to start	Start in the luteal phase	Our unit does not treat patients for fertility preservation
231 (72%)	45 (14%)	9 (2.8%)	36 (11.2%)
Do you use controlled ovarian hyperstimulation protocols for fertility preservation in breast cancer patients?
Yes	No	Our unit does not treat patients for fertility preservation
269 (83.8%)	25 (7.8%)	27 (8.4%)
In breast cancer patients, do you use FSH to stimulate the ovaries?
Yes	No	Our unit does not treat patients for fertility preservation
245 (76.3%)	49 (15.3%)	27 (8.4%)
In breast cancer patients, do you add aromatase inhibitors to the protocol?
Yes	No	Our unit does not treat patients for fertility preservation
237 (73.8%)	57 (17.8%)	27 (8.4%)